Artios Archives -

In its second licensing deal in the radio-oncology area in consecutive weeks, Novartis has agreed a $1.3 billion-plus

Novartis expands in radio-oncology again with $1.3bn Artios alliance

https://pharmaphorum.com/news/novartis-expands-in-radio-oncology-again-with-1-3bn-artios-alliance/

Germany’s Merck KGaA has joined with UK-based Artios Pharma in a potential multi-billion dollar deal to investigate novel

Merck KGaA signs DNA damage response cancer deal with Artios Pharma

https://pharmaphorum.com/news/merck-kgaa-signs-dna-damage-response-cancer-deal-with-artios-pharma/

Management team led development of AZ’s PARP drug Lynparza

UK’s Artios raises $84m to further DDR drug research

https://pharmaphorum.com/news/uks-artios-raises-84m-to-further-ddr-drug-research/

Artios